Browse > Article

Neuroprotective Effect of l-Deprenyl Against 6-OHDA-Induced Dopamine Depletion in Rat Striatum and 6-OHDA-Induced Oxidative Stress in SH-SY5Y Cells  

Kim Eun-Mi (Research Institute of Pharmaceutical Sciences, College of Pharmacy Ewha Womans University, National Institute of Scientific Investigation)
Choi Sinkyu (Research Institute of Pharmaceutical Sciences, College of Pharmacy Ewha Womans University)
Lee Kyunglim (Research Institute of Pharmaceutical Sciences, College of Pharmacy Ewha Womans University)
Kim Hwa-Jung (Research Institute of Pharmaceutical Sciences, College of Pharmacy Ewha Womans University)
Publication Information
YAKHAK HOEJI / v.49, no.4, 2005 , pp. 355-364 More about this Journal
Abstract
A neurotoxin, 6-hydroxydopamine (6-OHDA) has long been used to form a Parkinson's disease (PD) model by inducing the lesion in catecholaminergic pathways, particularly the nigrostriatal dopamine (DA) pathway. Whereas l-deprenyl, a selective inhibitor of monoamine oxidase (MAO) type B, is now widely used in the treatment of PD, the precise action mechanism of the drug remains elusive. In this study, we investigated whether l-deprenyl shows protective effect against the DA depletion induced by 6-OHDA in rat brain, and against 6-OHDA-induced neurotoxicity and oxidative stress in catecholaminergic neuroblastoma SH-SY5Y cells that are known to lack MAO-B activity. Pretreatment of l-deprenyl significantly enhanced the striatal DA, 3,4-dihydroxyphenylacetic acid, homovanilic acid, and 3-methoxytyramine levels compared to the untreated 6-OHDA-lesioned rat, indicating that l-deprenyl pretreatment prevents 6-OHDA-induced depletion of not only striatal dopamine but also its metabolites. Treatment of 6-OHDA for 24hrs decreased the cell viability and increase the generation of ROS in dose-dependent manners. We further investigated whether caspase activity is involved in the action of l-deprenyl. Treatment of l-deprenyl $(0.1\~100{\mu}M)$ did not produce any changes in 6-OHDA-induced cleavage of poly (ADP-ridose) polymerase in SH-SY5Y cells. Our results suggest that the neuroprotective effect of l-deprenyl against 6-OHDA is due to its increased scavenger activity, but independent of inhibition of MAO-B or caspase-3 activation.
Keywords
l-deprenyl; 6-hydroxydopamine (6-OHDA); reactive oxygen species (ROS); caspase-3;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gerlach, M., Riederer, P. and Youdim, M. B. H. : The molecular pharmacology of l-deprenyl. European Jounal of Pharmacology-Molecular Pharmacology Section 226, 97 (1992)   DOI   ScienceOn
2 Carrillo, M. C., Kanai, S., Nokubo, M. and Kitani, K. : Deprenyl induced activities of both superoxide dismutase & catalase but not of glutathione peroxidase in the striatum of young male rat. Life Sci. 48, 517 (1991)   DOI   ScienceOn
3 Walkinshaw, G. and Waters, C. M. : Neurotoxin induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63, 975 (1994)   DOI   ScienceOn
4 Ochu, E. E., Rothwell, N. J. and Waters, C. M. : Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J. Neurochem. 70, 2637 (1998)   DOI   ScienceOn
5 Knoll, J. : The striatal dopamine dependency of life span in male rats, longevity study with (-) deprenyl. Mech. Aging Dev. 46, 237 (1988)   DOI   ScienceOn
6 Cohen, G. and Spina, M. B. : Deprenyl supresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26, 689 (1989)   DOI   ScienceOn
7 Scarr, E., Wingerchuck, D. M., Juorio, A. V. and Paterson, I. A. : The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions. Neurochem. Res. 19, 153 (1994)   DOI   ScienceOn
8 Leist, M. and Nicotera, P. : Apoptosis, excitotoxicity and neuropathology. Experimental Cell Reasearch 239, 183 (1998)   DOI   ScienceOn
9 Mosmann, T. : Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 (1983)   DOI   PUBMED   ScienceOn
10 Tatton, W. G. and Chalmers-Redman, R. M. E. : Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration. Neurology 47(Supple 3), S171 (1996)   DOI
11 Kragten, E., Lalande, I., Zimmermann, K., Roggo, S., Schindler, P., Muller, D., Oostrum, J. V., Waldmeier, P. and Furst, P. : Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273, 5821 (1998)   DOI   ScienceOn
12 Oreland, L. : Monoamine oxidase, dopamine and Parkinson's disease. Acta. Neural. Scand. 84(Suppl 136), 60 (1991)
13 Gerlach, M., Youdim, M. B. H. and Riederer, P. : Is selegiline neuroprotective in Parkinson's disease? J. Neural Transm [suppl]. 41, 177 (1994).
14 Li, X. M., Juorio, A. V., Qi, J. and Boulton, A. A. : l-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells. J. Neurosci. Res. 53, 235 (1998)   DOI   ScienceOn
15 Mochizuki, H., Goto, K., Mori, H. and Mizuno, Y. : Histochemical detection of apoptosis in Parkinson's disease. J. Neural. Sci. 137, 120 (1996)   DOI   ScienceOn
16 Marti, M. J., James, C. J., Oo, T. F., Kelly, W. J. and Burke, R. E. : Early developmental destruction of terminals in the striatal target induce apoptosis in dopamine neurons of substantia nigra. J. Neurosci. 17, 2030 (1997)
17 Simonian, N. A. and Coyle, J. T. : Oxidative stress in neurodegenerative disease. Annu. Rev. Pharmacol. Toxicol. 36, 83 (1996)   DOI   ScienceOn
18 Heikkila, R. and Cohen, G. : Futher syudies on the generation of hydrogen peroxide by 6-hydroxydopamine : Potentiation by ascorbic acid. Molecular Pharmacology 8, 241 (1972)
19 Olanow, C. and Arendash, G. : Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7, 548 (1994)   DOI   ScienceOn
20 Spina, M. B., Squinto, S. P., Miller, J., Lindsay, R. M. and Hyman, C. : Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl 4-phenylpyridinium ion toxicity: Involvement of glutathione system. J. Neurochem. 59, 99 (1992)   DOI   PUBMED
21 Clow, A., Hussain, T., Glover, V., Sandler, M., Dexter, D. T. and Walker, M. : (-)-Deprenyl can induce soluble superoxide dismutase in rat striata. J. Neural Transm. [Gen Sect] 86, 77 (1991).   DOI   ScienceOn
22 Maruyama, W. Takahashi, T. and Naoi, M. : (-)-Deprenyl protects human doparninergic neuroblastoma SH-SY5Y cells from apoptosis induced by perowynitrite and nitric oxide. J. Neurochem. 70, 2510 (1998)   DOI   ScienceOn
23 Finberg, J. P. M., Wang, J., Goldstein, D. S., Kopin, I. J. and Bankiewics, K. S. : Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats. J. Neurochem. 65, 1213 (1995)   DOI   ScienceOn
24 Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. : Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
25 Wu, R. M., Chiueh, C. C., Pert, A. and Murphy, D. L. : Apperent antioxidant effect of l-deprenyl on hydroxyl adical formation and nigral injury elicited by $MPP^+$ in vivo. European Journal of Pharmacology 243, 241 (1993)   DOI   ScienceOn
26 Shimizu, S., Eguchi, Y., Kamiikie, W., Waguri, S., Uchiyama, Y., Matsuda, H. and Tsujimoto, Y. : Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 12, 2045 (1996)
27 Wu, R. M., Mohanakumar, K. P., Murphy, D. L. and Chiueh, C. C. : Antioxidant mechanism and protection of nigral neurons against $MPP^+$ toxicity by deprenyl (Selegiline). Annals New York Academy of Science. 738, 214 (1994)   DOI
28 Zuo, D. and Yu, P. H. : Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)depreny1. Progress in Brain Research 106, 199 (1995)
29 Cohen, G. : Oxidative Stress in Nervous System, In Sies, H.(ed.) : Oxidative stress. Academic Press, London 383 (1985)
30 Breese, G. and Traylor, T. D. : Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J. Pharmcol. Exp. Ther. 174, 413 (1970)
31 Grimsby, J.. Toth, M., Chen, K., Kumazawa, T., Klaidman, L., Adams, J. D., Karoum, F., Gal, J. and Shih, J. C. : Increased stress response and ${\beta}$-phenylethylamine in MAO-B deficient mice. Nat. Genet. 17, 206 (1997)   DOI   ScienceOn
32 Portera-Cailliau, C. and Hedreen, J. C., Price, D. L. and Koliatos, V. E. : Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775 (1995)
33 Lazebnik, Y. A., Kaufman, S. H., Desnoyers, S. Poirier, G. G. and Earnshaw, W. C. : Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346 (1994)   DOI   ScienceOn
34 Le, W., Jankovic, J., Xie, W., Kong, R. and Appel, S. H. : (-)-Deprenyl protection of l-methyl-4-phenylpyridium ion ($MPP^+$)-induced apoptosis independent of MAO-B inhibition. Neurosci. Let. 224, 197 (1997)   DOI   ScienceOn
35 Rodriguez-Gomez, J. A., Venero, J. L., Vizuete, M. L., Cano, J. and Machado, A. : Deprenyl induces the tyrosine hydroxylase enzyme in rat dopaminergic nigrostriatal system. Molecular Brain Research 46, 31 (1997)   DOI   ScienceOn
36 Maruyama, W, Naoi, M., Kasamatsu, T., Hashizume, Y., Takahashi, T., Kohda, K. and Dostert, P. An : Endogeneous dopaminergic neurotoxin, Nrnethyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neurochem. 69, 322 (1997)   DOI   ScienceOn
37 Blum, D., Wu, Y., Nissou, M. E, Benabid, A. L. and Verna, J. M. : p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Research 751, 139 (1997)   DOI   ScienceOn